Literature DB >> 7051227

Synergism in the folate pathway.

R J Harvey.   

Abstract

Synergism between inhibitors acting on different enzymes of a metabolic pathway can occur as a simple consequence of the nonlinear nature of normal enzyme kinetics. However, whether synergism does or does not occur is then determined entirely by the configuration of the pathway. Synergism between trimethoprim and sulfamethoxazole results from the cyclic configuration of the folate pathway.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7051227     DOI: 10.1093/clinids/4.2.255

Source DB:  PubMed          Journal:  Rev Infect Dis        ISSN: 0162-0886


  7 in total

Review 1.  Antibiotic combinations: should they be tested?

Authors:  G M Eliopoulos; C T Eliopoulos
Journal:  Clin Microbiol Rev       Date:  1988-04       Impact factor: 26.132

Review 2.  Bacterial adhesion: modulation by antibiotics with primary targets other than protein synthesis.

Authors:  D M Schifferli; E H Beachey
Journal:  Antimicrob Agents Chemother       Date:  1988-11       Impact factor: 5.191

3.  Anti-human immunodeficiency virus synergism by zidovudine (3'-azidothymidine) and didanosine (dideoxyinosine) contrasts with their additive inhibition of normal human marrow progenitor cells.

Authors:  R E Dornsife; M H St Clair; A T Huang; T J Panella; G W Koszalka; C L Burns; D R Averett
Journal:  Antimicrob Agents Chemother       Date:  1991-02       Impact factor: 5.191

Review 4.  Cotrimoxazole and neonatal kernicterus: a review.

Authors:  Baskaran Thyagarajan; Sharad S Deshpande
Journal:  Drug Chem Toxicol       Date:  2013-10-07       Impact factor: 3.356

5.  Potentiating effect of pyrimethamine and sulfadoxine against dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi.

Authors:  W Sirawaraporn; Y Yuthavong
Journal:  Antimicrob Agents Chemother       Date:  1986-05       Impact factor: 5.191

6.  Interactions of 1263W94 with other antiviral agents in inhibition of human cytomegalovirus replication.

Authors:  Dean W Selleseth; Christine L Talarico; Teresa Miller; Michael W Lutz; Karen K Biron; Robert J Harvey
Journal:  Antimicrob Agents Chemother       Date:  2003-04       Impact factor: 5.191

7.  Artificial Activation of Escherichia coli mazEF and hipBA Toxin-Antitoxin Systems by Antisense Peptide Nucleic Acids as an Antibacterial Strategy.

Authors:  Marcin Równicki; Tomasz Pieńko; Jakub Czarnecki; Monika Kolanowska; Dariusz Bartosik; Joanna Trylska
Journal:  Front Microbiol       Date:  2018-11-26       Impact factor: 5.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.